NCT03843827

Brief Summary

Invistigators study both supraglottic airway devices; the classic LMA and the I GEL mask are satisfactory devices providing high airway leaking pressures. Although both devices provide high airway leaking pressures, Invistigators study revealed that the I gel mask provides a better seal with the glottic aperture and shorter time of insertion than cLMA. Both devices showed also effective ventilation, more hemodynamic stability and no episode of hypoxia with minimal post-operative complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 18, 2019

Completed
19 days until next milestone

Study Start

First participant enrolled

March 9, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2019

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 18, 2019

Completed
Last Updated

May 21, 2019

Status Verified

May 1, 2019

Enrollment Period

2 months

First QC Date

February 8, 2019

Last Update Submit

May 20, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time of insertion of each device .

    Invistigators study Time of insertion of each device,Laryngeal Mask Airway and I gel

    Half an hour

Secondary Outcomes (6)

  • Leaking pressure of each device.

    Half an hour

  • Confirmation of position by fiber optic

    Half an hour

  • Blood Pressure

    24 hours

  • Heart Rate

    24 hours

  • Oxygen saturation

    24 hours

  • +1 more secondary outcomes

Study Arms (2)

Group A (LMA Group)

ACTIVE COMPARATOR

Active Comparator: Group A (LMA Group) LMA-Classic™ laryngeal mask airway (Classic™LMA) by Dr. Archie Brain into clinical practice in 1988 brought about a revolution in anesthesia. In the literature, there are over 2,500 studies supporting Classic™ LMA usage. Following the success and popularity of Classic™ LMA, many different variants of this device have been designed and marketed,trying to offer a simple and effective alternative to the endotracheal intubation.

Device: Laryngeal Mask Airway

Group B (I gel Group)

ACTIVE COMPARATOR

I gel is a new type of laryngeal mask and doesn't have an inflatable cuff. Because of its thermoplastic elastomer structure, it exactly adapts to the supraglottic tissue by binding with body temperature,thus minimising air leakage

Device: I gel Airway

Interventions

The aim of this study is to compare between cLMA and I gel regarding insertion success rate, the time of insertion, leaking pressure, assessment of position by fiber optic, hemodynamic, Spo2 for each device during insertion and maintenance of general anaesthesia and postoperative complications in obese patients

Group A (LMA Group)

I gel is a new type of laryngeal mask and doesn't have an inflatable cuff. Because of its thermoplastic elastomer structure, it exactly adapts to the supraglottic tissue by binding with body temperature, thus minimising air leakage

Group B (I gel Group)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adult healthy ASA II patients
  • both genders
  • BMI 35-40
  • aged 18 - 60 years
  • Mallampati grade I, II with airway score \< 4 according to El Ganzouri score during elective non abdominal surgery ≤ 2hour e.g diagnostic arthroscopy, hysteroscopy and cataract

You may not qualify if:

  • ASA class III or IV
  • Age \>60 years or \<18 years,
  • people with hypertension, diabetes, pregnancy, gastro oesophageal reflux disease, cardiovascular ,renal disease4. difficult mask ventilation , obstructive sleep apnea ,any position rather than supine , airway score ≥ 4 according to El Ganzouri score
  • \. any form of sore throat ,patients allergic to any drugs used in the study 6. PCV mode if measured tidal volume was lesser than 6 ml/kg it will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed Abdalla Mohamed

Cairo, 11451, Egypt

Location

MeSH Terms

Interventions

Laryngeal Masks

Intervention Hierarchy (Ancestors)

Intubation, IntratrachealAirway ManagementTherapeuticsIntubationInvestigative TechniquesMasksProtective DevicesEquipment and SuppliesPersonal Protective EquipmentManufactured MaterialsTechnology, Industry, and Agriculture

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
50Patients are randomly divided by computer designed lists and then concealed in closed envelopes into 2 equal groups: 1. Group A (n = 25), in which classic LMA is used for ventilation. 2. Group B (n = 25), in which I gel is used for ventilation.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Investigators hypothesize that both supraglottic devices, the classic LMA and i gel are effective in ventilation of obese patient.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesia &I.C.U and Pain Clinic, Cairo University

Study Record Dates

First Submitted

February 8, 2019

First Posted

February 18, 2019

Study Start

March 9, 2019

Primary Completion

May 15, 2019

Study Completion

May 18, 2019

Last Updated

May 21, 2019

Record last verified: 2019-05

Locations